In a groundbreaking development, a class of drugs known as semaglutide has been found to offer remarkable benefits for weight loss and cardiovascular health. Results from multiple studies involving thousands of participants have shed light on the diverse and sustained effects of these medications, including the popular Ozempic.
Weight Loss Benefits
Semaglutide, a GLP-1 receptor agonist, has demonstrated impressive weight loss capabilities in overweight and obese individuals. A large-scale study involving 17,000 adults reported an average weight loss of 10% of body weight and a waistline reduction of over 7 cm (2.7 inches) over a four-year period. Notably, more than half of the participants reduced their body mass index (BMI) by at least one category after two years, with 12% reaching a healthy BMI.
Cardiovascular Health Improvements
Beyond its weight loss effects, semaglutide has shown remarkable benefits for cardiovascular health. A study from University College London found that these drugs improve cardiovascular health by lowering risks such as heart disease and inflammation, regardless of the amount of weight loss or initial weight. These benefits are attributed to mechanisms such as improved blood sugar and blood pressure control, reduced inflammation, and direct effects on the heart and blood vessels.
Diverse and Sustained Effects
The positive outcomes of semaglutide have been observed across gender, race, age, and body size. Notably, the SELECT trial demonstrated a 20% reduction in risks of heart attack, stroke, and death from cardiovascular disease with over three years of semaglutide use, highlighting the sustained effects of these drugs.
Dr. Wendel’s SkinHaus Beauty is happy to announce that we now will be offering semaglutide treatments. Schedule a consultation with our office today and let us help you see if this treatment is the right fit for you.
